[1]李淑玲,程立军,马定勤,等.四子温肺汤治疗哮喘-慢阻肺重叠综合征急性期寒痰郁肺夹瘀证患者临床观察[J].西部中医药,2024,37(11):124-128.[doi:10.12174/j.issn.2096-9600.2024.11.27]
 LI Shuling,CHENG Lijun,MA Dingqin,et al.Clinical Observation on Sizi Wenfei Decoction in the Treatment of Acute Asthma-COPD Overlap Syndrome of Cold Phlegm Obstructing Lung and Blood Stasis Syndrome[J].Western Journal of Traditional Chinese Medicine,2024,37(11):124-128.[doi:10.12174/j.issn.2096-9600.2024.11.27]
点击复制

四子温肺汤治疗哮喘-慢阻肺重叠综合征急性期寒痰郁肺夹瘀证患者临床观察
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年11期
页码:
124-128
栏目:
临床研究
出版日期:
2024-11-15

文章信息/Info

Title:
Clinical Observation on Sizi Wenfei Decoction in the Treatment of Acute Asthma-COPD Overlap Syndrome of Cold Phlegm Obstructing Lung and Blood Stasis Syndrome
作者:
李淑玲1,2, 程立军3, 马定勤4, 王晓彬4, 豆根龙4, 孔德云4, 罗海霞4, 王兴茂4
1.甘肃省中医院,甘肃 兰州 730050
2.甘肃省中医药研究院,甘肃 兰州 730050
3.甘肃省康泰医院,甘肃 兰州 730046
4.永靖县中医院,甘肃 永靖 731600
Author(s):
LI Shuling1,2, CHENG Lijun3, MA Dingqin4, WANG Xiaobin4, DOU Genlong4, KONG Deyun4, LUO Haixia4, WANG Xingmao4
1.Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730050, China
2.Gansu Provincial Academy of Chinese Medicine, Lanzhou 730050, China
3.Kangtai Hospital, Lanzhou 730046, China
4.Yongjing County Hospital of Traditional Chinese Medicine, Yongjing 731600, China
关键词:
哮喘-慢阻肺重叠综合征急性期寒痰郁肺夹瘀证肺功能炎症因子临床疗效
Keywords:
asthma-COPD overlap syndrome acute stagecold phlegm obstructing lung and blood stasis patternlung functioninflammatory factorsclinical effects
分类号:
R256.12
DOI:
10.12174/j.issn.2096-9600.2024.11.27
文献标志码:
B
摘要:
目的探讨四子温肺汤对哮喘-慢阻肺重叠综合征(Asthma-COPD overlap syndrome,ACOS)急性期寒痰郁肺夹瘀证患者肺功能、炎症因子水平及临床疗效的影响。 方法将88例ACOS患者按照治疗方案不同分为对照组和观察组,每组44例。对照组采用布地奈德福莫特罗吸入粉雾剂(Ⅱ)联合噻托溴铵吸入粉雾剂进行治疗,而观察组则在对照组治疗方案的基础上,联合给予四子温肺汤治疗。两组均连续治疗10天。比较两组治疗前后肺功能指标,血清炎性因子[超敏C反应蛋白(hypersensitive C-reactive protein,hs-CRP)、白细胞介素17(interleukin,IL-17)、白细胞介素4(interleukin,IL-4)]水平、哮喘控制测试(asthma control test,ACT)评分、慢性阻塞性肺疾病评估测试(COPD assessment test,CAT)评分和临床疗效、不良反应发生情况。 结果治疗后两组用力肺活量(forced vital capacity,FVC)、第1秒用力呼气容积(forced expiratory volume in one second,FEV1)、FEV1/FVC与呼气流量峰值(peak expiratory flow,PEF)均较治疗前升高(P<0.05),血清炎症因子水平、CAT评分均较治疗前降低(P<0.05),ACT评分增加(P<0.05);且上述指标观察组与对照组比较,差异均有统计学意义(P<0.05)。观察组总有效率[97.72%(43/44)]高于对照组[90.91%(40/44)](P<0.05);两组不良反应发生率无明显差异(P>0.05)。 结论四子温肺汤治疗ACOS寒痰郁肺夹瘀证患者,能改善患者肺功能,控制哮喘症状,降低血清炎性反应,提高临床疗效。
Abstract:
ObjectiveTo explore the influence of Sizi Wenfei decoction (four-seeds warming-lung decoction) on lung function, and the levels of inflammatory factors and clinical effects of patients with acute asthma-COPD overlap syndrome (ACOS) of cold phlegm obstructing lung and blood stasis pattern. MethodsAll 88 ACOS patients were divided into the control group and the observation group according to therapeutic regimen, 44 cases in each group. The control group was treated with Budesneide formoterol inhalation powder Ⅱ and tiotropium inhalation powder, and Sizi Wenfei decoction was given to the observation group, and both groups were treated for ten days continuously. To compare the indexes of lung function, the levels of serum inflammatory factors including hs-CRP, IL-17 and IL-4, and ACT scores, CAT scores, clinical effects and the incidences of adverse reaction before and after the treatment in the two groups. ResultsAfter the treatment, FEV1, FVC, FEV1/FVC and PEF were elevated than before the treatment (P<0.05), the levels of serum inflammatory factors and CAT scores were reduced than before the treatment (P<0.05), ACT scores were increased (P<0.05); and the difference had statistical meaning in the above indexes between the observation group and the control group (P<0.05). Total effective rate of the observation group was [97.72%(43/44)], higher than [90.91%(40/44)] of the control group (P<0.05); there was no significant difference in the incidences of adverse reaction between both groups (P>0.05). ConclusionSizi Wenfei decoction in the treatment of ACOS of cold phlegm obstructing lung and blood stasis pattern could improve lung function, control asthma symptoms, reduce serum inflammatory reaction and raise clinical effects.

相似文献/References:

[1]杨建新,王春晓,安德明,等.乌头健肾汤治疗急性期腰椎间盘突出症100例[J].西部中医药,2015,28(08):87.
[2]刘晓霞,吴海娟.西医常规联合平衡火罐治疗慢性阻塞性肺疾病急性期临床观察[J].西部中医药,2021,34(11):124.[doi:10.12174/j.issn.2096-9600.2021.11.28]
 LIU Xiaoxia,WU Haijuan.Clinical Observation on Balance Cupping and Conventional Western Medicine in the Treatment of AECOPD[J].Western Journal of Traditional Chinese Medicine,2021,34(11):124.[doi:10.12174/j.issn.2096-9600.2021.11.28]
[3]许玉军,孙培养,王涛,等.基于个体症状变化对脑梗死急性期患者实施PBL式健康教育的效果观察[J].西部中医药,2020,33(08):141.[doi:10.12174/j.issn.1004-6852.2020.08.39]
 XU Yujun,SUN Peiyang,WANG Tao,et al.Observation on the Effects of PBL Health Education on the Patients with Acute Cerebral Infarction Based on Individual Symptoms Changes[J].Western Journal of Traditional Chinese Medicine,2020,33(11):141.[doi:10.12174/j.issn.1004-6852.2020.08.39]
[4]庞瑞康,范郁山.壮医药线点灸结合针刺治疗急性期带状疱疹疗效评价及对其镇痛机制的探讨[J].西部中医药,2022,35(08):62.[doi:10.12174/j.issn.2096-9600.2022.08.15]
 PANG Ruikang,FAN Yushan.Clinical Evaluation of Zhuang Medicine Medicated Thread Dotted Moxibustion and Acupuncture in the Treatment of Acute Herpes Zoster and Discussion on Analgesia Mechanism[J].Western Journal of Traditional Chinese Medicine,2022,35(11):62.[doi:10.12174/j.issn.2096-9600.2022.08.15]
[5]孙玮,陈英华,王浩宇,等.多功能套针浮刺治疗腰椎间盘突出症急性期患者临床观察[J].西部中医药,2024,37(07):150.[doi:10.12174/j.issn.2096-9600.2024.07.36]
 SUN Wei,CHEN Yinghua,WANG Haoyu,et al.Clinical Observation on Multifunctional Trocar-acupuncture Floating Needling in the Treatment of Acute Lumbar Disc Herniation[J].Western Journal of Traditional Chinese Medicine,2024,37(11):150.[doi:10.12174/j.issn.2096-9600.2024.07.36]

备注/Memo

备注/Memo:
李淑玲(1978—),女,硕士学位,主治医师。研究方向:内科疾病的中医药诊治。国家中医药管理局“十二五”重点学科中医文化学建设项目(国中医药教育便函〔2012〕170号);甘肃省中医药重点专科中医药信息学建设项目(甘中卫函〔2013〕462号)。
更新日期/Last Update: 2024-11-15